Annual General Meeting of Neurosoft S.A.

Athens, 21st June 2012

Press release

Annual General Meeting of Neurosoft S.A.
Athens, 21st June 2012 The Company announces that the Annual General Meeting was held today, Thursday, 21 June 2012 and was attended by 7 shareholders, either in person or by proxy, representing 21.403.138 shares out of a total of 25.000.000 shares, i.e. 85,61% of the paid up share capital. Neurosoft, traded on Milan's AIM Italia market (GRS802003004, Reuters NRST.MI, Bloomberg NRST:IM), has Integrae SIM SpA as its Nominated Adviser. The shareholders adopted the following resolutions: 1. approved the annual corporate and consolidated financial statements for financial year 2011. 2. approved to discharge the Directors and the Auditors from any liability related to the results of the financial year 2011. 3. approved the remuneration payable to the Board of Directors for the financial years 2011 and 2012 and for the first half of 2013 . 4. approved the appointment of International Certified & Registered Auditors' SA as Certified Auditors for the financial year 2012. 5. permitted the members of the Board of Directors to be a shareholder and/or director of any company, if there are any. So far, no such participation or intent of participation has been reported. 6. approved the appointment of Mr. Ioannis Papanikolaou as Independent Director following the resignation of Mrs Evanthia Paraskevoupoulou. The résumé of the board of directors can be found in the Investor Relations section of www.neurosoft.gr 7. approved the company's stringent cost cutting and reorganization program which includes the following: a) further reduction in payroll costs through a decrease in personnel numbers b) further minimization of outsourcing contracts c) further negotiation in the decrease in 3rd party contract amounts. In addition the company continues into focusing in core businesses by

1

extending product lines and geographical regions as it is reinforcing Sales and Research & Development. 8. approved the Corporate Governance Code and Board of Directors reestablishment. Two members of the Board of Directors have been nominated as independent Directors, Mr. Ioannis Papanikolaou, and Mr. Andreas Theodorou and four members have been nominated as non executive Directors, Mrs Efthalia Siamani, Mr. Ioannis Papanikolaou, Mr. Andreas Theodorou and Mr. Apostolos Koukouvinos. According to the Corporate Governance Code an Internal Audit Committee has been appointed which consists of the following members: Mrs. Efthalia Siamani, Mr. Ioannis Papanikolaou and Mr. Andreas Theodorou. 9. Further Announcements No dividend will be allocated by the company for year 2011 **********
Neurosoft S.A., a Greek company listed on the AIM Italia market, organized and managed by the Italian Stock Exchange (ISIN GRS802003004, Reuters NRST.MI, Bloomberg NRST:IM), today is a software provider supplying solutions that optimize business and operational processes with a view to maximize customer profitability. Neurosoft's innovative integrated software systems in factoring, sports betting, business intelligence, liability management, transactional systems, and the implementation of mission critical applications have provided tools to financial institutions, stock exchanges, telecom companies and sports betting operators to increase operating efficiencies, act on well-depicted real-time risk and liability analysis, and increase revenues and bottom line capitalizing on sophisticated predictive analytics. Neurosoft was founded in 1994 and became the first company to be floated in the AIM Italia market of the Milan Stock Exchange in 2009. Based in Athens, Neurosoft has a multinational presence in Romania, Albania, Serbia, Bulgaria and Cyprus. Integrae SIM S.p.A is Neurosoft's Nominated Adviser for the AIM Italia market.

On behalf of Neurosoft SA, Alexandra Andriopoulou email: a.andriopoulou@neurosoft.gr, tel.:+30 210 6855061 Nominated Adviser, Integrae SIM SpA, Luca Di Liddo email: luca.diliddo@integraesim.it, Luigi Giannotta email: luigi.giannott@integraesim.it , tel.: +39 02 78625302

2